LGGs with IDH wild‐type, 1p/19q non‐codeletion, and TERT mutation can progress to more aggressive gliomas, such as anaplastic glioma and secondary glioblastoma (GBM).7 This evidence concerns the gene IDH1 and central nervous system cancer.